Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2198-6584
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study ; day:2 ; month:4 ; year:2021 ; pages:1-13
Rheumatology and therapy ; (2.4.2021), 1-13

Creator
Pierini, Florencia S.
Botta, Eliana
Soriano, Enrique R.
Martin, Maximiliano
Boero, Laura
Meroño, Tomás
Saez, María Soledad
Lozano Chiappe, Ezequiel
Cerda, Osvaldo
Citera, Gustavo
Gandino, Ignacio
Rosa, Javier
Sorroche, Patricia
Kontush, Anatol
Brites, Fernando
Contributor
SpringerLink (Online service)

DOI
10.1007/s40744-021-00304-0
URN
urn:nbn:de:101:1-2021052621260538813836
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Pierini, Florencia S.
  • Botta, Eliana
  • Soriano, Enrique R.
  • Martin, Maximiliano
  • Boero, Laura
  • Meroño, Tomás
  • Saez, María Soledad
  • Lozano Chiappe, Ezequiel
  • Cerda, Osvaldo
  • Citera, Gustavo
  • Gandino, Ignacio
  • Rosa, Javier
  • Sorroche, Patricia
  • Kontush, Anatol
  • Brites, Fernando
  • SpringerLink (Online service)

Other Objects (12)

Tocilizumab: A Review in Rheumatoid Arthritis

Tocilizumab: A Review in Rheumatoid Arthritis

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis

Association of HDL and LDL levels with osteoporosis in rheumatoid arthritis: a retrospective cohort study

Association of HDL and LDL levels with osteoporosis in rheumatoid arthritis: a retrospective cohort study

Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials

Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials

Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis

Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis

A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab

A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry

Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy

Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy

Untersuchungen zur Charakterisierung von LDL- und HDL-Rezeptoren

Hochschulschrift

Untersuchungen zur Charakterisierung von LDL- und HDL-Rezeptoren

Wirkung der Lipoproteine LDL, moxLDL und HDL auf die Thrombozytenfunktion im Blut

Wirkung der Lipoproteine LDL, moxLDL und HDL auf die Thrombozytenfunktion im Blut

Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT

Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series

Related objects